Abstract
Fuzheng-Huayu formula (FZHY), a Chinese herbal mixture prescription, has been proven effective in treating liver fibrosis and cirrhosis in both clinical trials and animal experiments. In this study we assessed the metabolic mechanisms of traditional Chinese medicine (TCM) syndrome-based FZHY treatment in liver cirrhosis (LC). A total of 113 participants, including 50 healthy controls and 63 LC patients, were recruited. According to the diagnosis and differentiation of the TCM syndromes, the LC patients were classified into 5 TCM syndrome groups including the liver stagnation syndrome (LSS), spleen deficiency and damp overabundance syndrome (SDDOS), damp-heat accumulation syndrome (DHAS), liver-kidney Yin deficiency syndrome (LKYDS), and blood stagnation syndrome (BSS), and administered FZHY for 6 months. FZHY treatment significantly decreased serum levels of hyaluronic acid (HA), a biochemical marker for LC, as well as TCM syndrome scores (the TCM syndrome scores were decreased in all the groups with significant decreases in the LSS and LKYDS groups). Furthermore, FZHY treatment gradually shifted the metabolic profiles of LC patients from a pathologic state to a healthy state, especially in LC patients with LSS and LKYDS. Twenty-two differently altered metabolites (DAMs) were identified, including carbohydrates, amino acids, fatty acids, etc with 9 DAMs in LSS patients, 9 in LKYDS patients, and 4 in other patients. The metabolic pathways involved in the conversion of amino acids and the body's detoxification process were regulated first, followed by the pathways involved in the body's energy supply process. In conclusion, the evaluation of the effect of TCM syndrome-based FZHY treatment show that FZHY has a better effect on LKYDS and LSS than on the other TCM syndromes, and the metabolic mechanisms might be involved in the increased detoxification function in LKYDS and the improvement of energy supply in LSS, which provides important evidence for the clinical application of TCM syndrome-based treatment.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Schuppan D, Afdhal NH . Liver cirrhosis. Lancet 2008; 371: 838–51.
Tsochatzis EA, Bosch J, Burroughs AK . Liver cirrhosis. Lancet 2014; 383: 1749–61.
Liu P, Liu C, Xu LM, Hu YY, Xue HM, et al. Effects of Fuzheng Huayu 319 recipe on liver fibrosis in chronic hepatitis B. World J Gastroenterol 1998; 4: 348–53.
Song YN, Sun JJ, Lu YY, Xu LM, Gao YQ, et al. Therapeutic efficacy of fuzheng-huayu tablet based traditional chinese medicine syndrome differentiation on hepatitis-B-caused cirrhosis: a multicenter double-blind randomized controlled trail. Evid Based Complement Alternat Med 2013; 2013: 709305.
Chen Q, Wu F, Wang M, Dong S, Liu Y, Lu Y, et al. Transcriptional profiling and mirna-target network analysis identify potential biomarkers for efficacy evaluation of Fuzheng-Huayu formula-treated hepatitis B caused liver cirrhosis. Int J Mol Sci 2016; 17: 883.
Li XM, Peng JH, Sun ZL, Tian HJ, Duan XH, et al. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-beta/Smad signaling pathways. Acta Pharmacol Sin 2016; 37: 783–93.
Yang T, Liu S, Wang CH, Tao YY, Zhou H, et al. Comparative pharmacokinetic and tissue distribution profiles of four major bioactive components in normal and hepatic fibrosis rats after oral administration of Fuzheng Huayu recipe. J Pharm Biomed Anal 2015; 114: 152–8.
Tao YY, Yan XC, Zhou T, Shen L, Liu ZL, Liu CH . Fuzheng Huayu recipe alleviates hepatic fibrosis via inhibiting TNF-alpha induced hepatocyte apoptosis. BMC Complement Altern Med 2014; 14: 449.
Pan Q, Wang YQ, Li GM, Duan XY, Fan JG . Fuzheng Huayu Recipe ameliorates liver fibrosis by restoring balance between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition in hepatic stellate cells. Biomed Res Int 2015; 2015: 935903.
Wang X, Xie G, Wang X, Zhou M, Yu H, Lin Y . Urinary metabolite profiling offers potential for differentiation of liver-kidney yin deficiency and dampness-heat internal smoldering syndromes in posthepatitis B cirrhosis patients. Evid Based Complement Alternat Med 2015; 2015: 464969.
Song YN, Zhang H, Guan Y, Peng JH, Lu YY, Hu YY, et al. Classification of traditional Chinese medicine syndromes in patients with chronic hepatitis b by seldi-based proteinchip analysis. Evid Based Complement Alternat Med 2012; 2012: 626320.
Zhou HP . Clinical study of liver cirrhosis treated by integrated traditional Chinese and western medicine. Chin J Integr Tradit Western Med 2013; 21: 199–201.
Nicholson JK, Lindon JC, Holmes E . Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999; 29: 1181–9.
Goodacre R . Metabolomics of a superorganism. J Nutr 137: 259S–266S.
Chen T, Xie G, Wang X, Fan J, Qiu Y, Zheng X, et al. Serum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinoma. Mol Cell Proteomics 2007; 10: M110004945.
Chinese Association of Integrative Medicine LDC . Guideline for the diagnosis and treatment of liver fibrosis with integrative medicine. J Chin Integr Med 2006; 4: 551–5.
Song YN, Dong S, Wei B, Liu P, Zhang YY, Su SB . Metabolomic mechanisms of gypenoside against liver fibrosis in rats: An integrative analysis of proteomics and metabolomics data. PLoS One 2017; 12: e0173598.
Dong S, Chen QL, Su SB . Curative effects of Fuzheng Huayu on liver fibrosis and cirrhosis: a meta-analysis. Evid Based Complement Alternat Med 2015; 2015: 125659.
Muting D, Kalk JF, Fischer R, Wuzel H, Reikowski J . Hepatic detoxification and hepatic function in chronic active hepatitis with and without cirrhosis. Dig Dis Sci 1988; 33: 41–6.
Ukida M, Takao T . Amino acid metabolism in liver cirrhosis. Nihon Rinsho 1992; 50: 1604–8.
Maier KP, Talke H, Gerok W . Activities of urea-cycle enzymes in chronic liver disease. Klin Wochenschr 1979; 57: 661–5.
Ren XQ, Jiang SQ, Lu YQ, Luo XP, Guo HQ, et al. The relationship of liver kidney Yin deficiency syndrome, blood lipids, energy metabolism and free radical reaction. Henan Tradit Chin Med 1996; 16: 346–8.
Kasahara H, Ohyanagi H, Saitoh Y . Changes of gluconeogenesis and alanine metabolism following partial hepatectomy in normal and cirrhotic rats. Nihon Geka Gakkai Zasshi 1988; 89: 365–75.
Hanai T, Shiraki M, Nishimura K, Imai K, Suetsugu A, et al. Free fatty acid as a marker of energy malnutrition in liver cirrhosis. Hepatol Res 2014; 44: 218–28.
Xiao M, Zhou YY . Comparison of behavior indexes of different kinds of liver-qi stagnation anamal models. Chin J Tradit Med Sci Technol 2015; 22: 123–4.
Wang WM, Huang YH, Xiong ZF, Xu ZX, Sheng GG . Study on urine metabonomics for rat model with stagnation of liver-Qi syndrome. Chin J Integr Tradit Western Med Liver Dis 2010; 20: 102–5.
Acknowledgements
This work was supported by the Key Program of the National Natural Science Foundation of China (No 81330084), the National Science and Technology Major Project of China (No 2009ZX09311-003) and the E-institutes of Shanghai Municipal Education Commission (No E 03008).
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Supplementary Figure S1
The VIP plot of the metabolism in LC regulated by FZHY treatment. (JPG 64 kb)
Supplementary Table
Supplementary TableS S1–S3 (DOC 143 kb)
Rights and permissions
About this article
Cite this article
Song, Yn., Chen, J., Cai, Ff. et al. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes. Acta Pharmacol Sin 39, 942–951 (2018). https://doi.org/10.1038/aps.2017.101
Received:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/aps.2017.101
Keywords
This article is cited by
-
Integrated analyses to explore the mechanism of Gancao Renshen Zhixue Decoction in treating liver cirrhosis
Scientific Reports (2025)
-
Low-risk individuals with primary biliary cholangitis and significant liver stiffness: prognosis and treatment
Hepatology International (2025)
-
Systems biology approaches in the study of Chinese herbal formulae
Chinese Medicine (2018)
-
New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine
Acta Pharmacologica Sinica (2018)
